Project Grant R01HL171997

Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $718K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This Project Grant award of $1,357,132.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund research conducted by the University of Texas Health Science Center at Houston (UTHealth) to investigate the role of EPAC signaling in regulating renal sodium handling and hypertension. The research aims to: Determine the salt-sensitivity associated with EPAC-induced...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $636,822 to Western University of Health Sciences to conduct research on the cooperative modulation of piezo ion channels, which are essential for sensing mechanical forces in the cardiovascular system. The key research objectives are to: 1) use molecular dynamics simulations to study the interactions between piezo channel structures in...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $641,816 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Rutgers, The State University of New Jersey to conduct research on the role of connexin hemichannels in the endothelium of resistance arteries. The 5-year project, beginning January 15, 2025, aims to identify the mechanisms through which the TRPV4 ion channel activates endothelial connexin 43 (CX43) hemichannels, a critical step in...
This federal Project Grant award, totaling $2,158,428 and funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research aimed at investigating the role of the glycolytic enzyme pyruvate kinase M2 (PKM2) in mediating hypertension and vascular remodeling. The award supports three specific aims: 1) Studying the involvement of PKM2 activation in vascular smooth muscle cells (VSMCs) in hypertension and vascular...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $934,946 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Virginia Commonwealth University (VCU). The grant supports research to investigate the role of the acid ceramidase-sphingosine-1-phosphate (AC-S1P) pathway in the kidney's regulation of sodium excretion and its potential contribution to salt-sensitive hypertension. Specifically, the research...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $114,180.00 to the Regents of the University of Minnesota to conduct research on renal afferent nerve circuitry and its influence on blood pressure regulation. The project aims to 1) elucidate the central terminations and regional specificity of renal afferents, and 2) identify...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $717,236 to The University of Iowa to study the role of neuronal primary cilia in hypertension, autonomic dysfunction, and body fluid imbalance. The goal is to evaluate how conditional ablation of cilia in the supraoptic nucleus affects blood pressure, drinking, urine volume, sodium concentration, plasma osmolality, regional sympathetic...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $2,042,978 to the University of South Alabama to investigate the molecular mechanisms by which the protein progranulin regulates endothelial function and blood pressure control. The key objectives are to determine how reduced endothelial progranulin levels contribute to the development and progression of hypertension through...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) is funding research to investigate the role of arterial baroreceptors in hypertension. The $136,350 award to the Georgia State University Research Foundation aims to unravel the genetic identity of arterial baroreceptors and link their gene expression to neuronal function during blood pressure regulation. During the initial K99 career...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Federal Grant Program CFDA 93.837 - Cardiovascular Diseases Research, provides $249,000.00 in funding to Texas A&M University System Health Science Center to conduct research on the regulation of vasopressin neurons in a rodent model of heart failure. The key goals of the research are to investigate how vasopressin neurons self-regulate their excitability and paracrine release of vasopressin, and...

PANX1-PIEZO1 INTERACTIONS REGULATE RENIN RELEASE - || ABSTRACT HYPERTENSION IS THE MOST COMMON PATHOLOGICAL INDICATOR FOR CARDIOVASCULAR DISEASES. THE KEY BIOLOGICAL SYSTEM THAT REGULATES BLOOD PRESSURE IS THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS); ITS DYSREGULATION AT ALMOST ANY LEVEL CAN PRECIPITATE HYPERTENSION. FOR THIS REASON, PATHWAYS IN THE RAAS CAN BE MANIPULATED FOR PHARMACOLOGICAL INTERVENTIONS (E.G., ACE INHIBITORS). IN THIS APPLICATION WE INTERROGATE THE RELEASE OF RENIN, THE RATE LIMITING STEP OF ACTIVATION OF THE RAAS, FROM JUXTAGLOMERULAR (JG) CELLS IN THE AFFERENT ARTERIOLES, AND PROVIDE EXCITING PRELIMINARY DATA TO DEMONSTRATE A NOVEL MECHANICALLY-SENSITIVE SIGNALING AXIS. IN PARTICULAR, THE APPLICATION IS FOCUSED ON OUR RECENT WORK INVOLVING PANX1 CHANNELS IN JG CELLS, AND HOW THEY MAY BE COUPLED TO THE BONA FIDE MECHANICALLY SENSITIVE PIEZO1 CHANNELS SPECIFICALLY FOUND IN JG CELLS. INTERESTINGLY, WE HAVE IDENTIFIED A ROLE FOR ESTROGEN RECEPTOR ALPHA THAT MAY PROVIDE A LEVEL OF PROTECTION WHEN COUPLED WITH PIEZO1. BASED ON OUR PRELIMINARY DATA, WE HYPOTHESIZE RENIN RELEASE CAN BE DICTATED BY MECHANICALLY SENSITIVE PIEZO- PANX1 COMPLEXES IN JG CELLS THAT ARE REGULATED BY SEX DEPENDENT AND INDEPENDENT FEEDBACK. WE PROPOSE THREE AIMS TO TEST THIS: 1. PROTEIN KINASE A (PKA) REGULATION OF PANX1 CHANNELS; 2. CHANGES IN AFFERENT ARTERIOLE PRESSURE IS SENSED BY PIEZO1 AND CAN REGULATE PANX1 AND 3. ESTROGEN RECEPTOR A REGULATES PIEZO CHANNEL ACTIVITY. IN ORDER TO ACCOMPLISH THESE AIMS, WE HAVE DERIVED NOVEL MOUSE LINES (INCLUDING PANX1T20A AND REN1D- CRE/PIEZO1FL/FL) AND STATE-OF-THE-ART TECHNIQUES (E.G., ISOLATED RENIN SECRETING CELLS, ISOLATED KIDNEY PERFUSION, CALCIUM IMAGING ON KIDNEY SLICES). THIS APPLICATION IS COMPOSED OF AN INTERNATIONALLY RENOWNED TEAM OF EXPERTS, WITH ALL PROPOSED KNOCKOUT MICE BEING ON HAND, AND ROBUST PRELIMINARY DATA. WE BELIEVE THE DATA WILL PROVIDE AN IMPORTANT NEW LAYER OF REGULATION IN THE RAAS CAPABLE OF PHARMACOLOGICAL INTERVENTION.

Posted 6/1/24, 12:00 AM